Cargando…
Hemizygous loss of function mutations in CLCN5 causing end-stage kidney disease without Dent disease phenotype
Dent disease type 1 is suspected in the presence of a complete phenotype of low molecular weight (LMW) proteinuria, hypercalciuria and at least one of the following: nephrocalcinosis, nephrolithiasis, haematuria, hypophosphatemia or chronic kidney disease (CKD). We present two brothers who presented...
Autores principales: | Leggatt, Gary, Gast, Christine, Gilbert, Rodney D, Veighey, Kristin, Rahman, Tahmina, Ennis, Sarah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871842/ https://www.ncbi.nlm.nih.gov/pubmed/36726441 http://dx.doi.org/10.1093/ckj/sfac127 |
Ejemplares similares
-
A Role for Genetic Modifiers in Tubulointerstitial Kidney Diseases
por: Leggatt, Gary P., et al.
Publicado: (2023) -
Case report: a Chinese girl with dent disease 1 and turner syndrome due to a hemizygous CLCN5 gene mutation and Isochromosome (Xq)
por: Ye, Yuhong, et al.
Publicado: (2020) -
Nephrolithiasis, kidney failure and bone disorders in Dent disease patients with and without CLCN5 mutations
por: Anglani, Franca, et al.
Publicado: (2015) -
A novel likely pathogenic CLCN5 variant in Dent’s disease
por: Hayward, S, et al.
Publicado: (2023) -
The Site and Type of CLCN5 Genetic Variation Impact the Resulting Dent Disease-1 Phenotype
por: Arnous, Muhammad G., et al.
Publicado: (2023)